National Research (NASDAQ:NRC) Stock Price Down 1.9%

National Research Co. (NASDAQ:NRCGet Rating) shares dropped 1.9% during trading on Friday . The stock traded as low as $35.39 and last traded at $35.39. Approximately 1 shares changed hands during mid-day trading, a decline of 100% from the average daily volume of 24,848 shares. The stock had previously closed at $36.07.

National Research Stock Up 1.1 %

The company has a quick ratio of 1.31, a current ratio of 1.31 and a debt-to-equity ratio of 0.29. The company’s fifty day simple moving average is $36.33 and its 200 day simple moving average is $36.73. The firm has a market capitalization of $918.18 million, a PE ratio of 25.49 and a beta of 0.66.

National Research Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 14th. Shareholders of record on Friday, September 30th will be issued a $0.24 dividend. The ex-dividend date is Thursday, September 29th. This represents a $0.96 annualized dividend and a yield of 2.63%. National Research’s dividend payout ratio (DPR) is presently 67.13%.

Institutional Trading of National Research

Several institutional investors and hedge funds have recently bought and sold shares of NRC. Hardy Reed LLC purchased a new position in shares of National Research during the first quarter valued at approximately $37,000. Lazard Asset Management LLC purchased a new position in shares of National Research during the first quarter valued at approximately $49,000. Amalgamated Bank purchased a new position in shares of National Research during the first quarter valued at approximately $90,000. BNP Paribas Arbitrage SA lifted its holdings in shares of National Research by 38.5% during the second quarter. BNP Paribas Arbitrage SA now owns 3,496 shares of the company’s stock valued at $134,000 after purchasing an additional 971 shares during the last quarter. Finally, Legal & General Group Plc lifted its holdings in shares of National Research by 9.6% during the second quarter. Legal & General Group Plc now owns 5,597 shares of the company’s stock valued at $214,000 after purchasing an additional 492 shares during the last quarter. 67.51% of the stock is currently owned by hedge funds and other institutional investors.

National Research Company Profile

(Get Rating)

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty.

Featured Stories

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.